Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an electrolyte supplement used to treat or prevent hypomagnesemia and as a tocolytic agent. It is also used in the management of certain cardiac arrhythmias and pre-eclampsia/eclampsia.
## Primary Indications
* Treatment and prevention of hypomagnesemia.
* Tocolysis (prevention of preterm labor).
* Management of severe pre-eclampsia and eclampsia.
* Treatment of torsades de pointes.
* Adjunct in status asthmaticus.
## Adult Dosing
* **Hypomagnesemia:**
* **Mild to moderate deficiency:** 1 to 6 grams of magnesium sulfate (8 to 48 mEq) intravenously or intramuscularly every 4 to 6 hours for 4 doses.
* **Severe deficiency:** 4 to 6 grams of magnesium sulfate (32 to 48 mEq) diluted in 1000 mL of intravenous fluid (e.g., D5W or NS) infused over 4 to 12 hours. Subsequent doses of 1 to 6 grams (8 to 48 mEq) may be given every 4 to 6 hours as needed.
* **Intramuscular (IM):** 1 gram (8 mEq) every 6 hours for 4 doses. Dilute IM injections with 0.5 mL of 1% procaine or lidocaine to reduce pain.
* **Tocolysis:** 4 to 6 grams of magnesium sulfate (32 to 48 mEq) IV bolus over 20 to 30 minutes, followed by a maintenance infusion of 1 to 2 grams per hour (8 to 16 mEq/hour). Dosing and duration are often guided by institutional protocol and clinical response.
* **Pre-eclampsia/Eclampsia:**
* **Loading dose:** 4 to 6 grams of magnesium sulfate (32 to 48 mEq) IV infused over 5 to 10 minutes.
* **Maintenance infusion:** 1 to 2 grams per hour (8 to 16 mEq/hour). Some protocols may use IM dosing for maintenance.
* **Torsades de Pointes:** 1 to 2 grams of magnesium sulfate (8 to 16 mEq) diluted in 10 mL D5W IV over 5 to 10 minutes. This can be followed by an infusion of 0.5 to 1 gram per hour (4 to 8 mEq/hour).
* **Status Asthmaticus:** 1 to 2 grams of magnesium sulfate (8 to 16 mEq) IV infused over 15 to 30 minutes.
## Pediatric Dosing
* **Hypomagnesemia:** Dosing is highly variable and guided by serum magnesium levels and institutional protocols. Generally, a dose of 25 to 50 mg/kg/dose (0.2 to 0.4 mEq/kg/dose) IV or IM every 4 to 6 hours for 4 doses. Maximum single dose typically 2 grams.
* **Tocolysis:** Not routinely recommended due to limited efficacy and potential for adverse effects.
* **Eclampsia:** Similar to adult dosing, but specific pediatric guidelines may vary.
* **Status Asthmaticus:** 25 to 50 mg/kg IV infused over 15 to 30 minutes. Maximum dose typically 2 grams.
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. In patients with impaired renal function, doses should be reduced, and serum magnesium levels should be closely monitored. Caution is advised, and dosing should be guided by clinical response and magnesium levels.
## Contraindications
* Hypermagnesemia.
* Heart block or myocardial damage (relative contraindication for rapid IV administration).
* Hypersensitivity to magnesium sulfate.
## Adverse Effects
Common: Flushing, sweating, hypotension, nausea, vomiting, thirst, and hyporeflexia.
Serious: Respiratory depression, cardiac arrhythmias, cardiac arrest, loss of deep tendon reflexes, and coma.
## Key Drug Interactions
* **Neuromuscular Blockers:** Magnesium can potentiate the effects of neuromuscular blocking agents, leading to prolonged neuromuscular blockade.
* **Calcium:** Concurrent administration of calcium may antagonize the effects of magnesium.
* **Nifedipine:** May increase the risk of hypotension and hyporeflexia when used with magnesium sulfate.
## Monitoring
* **Serum Magnesium Levels:** Essential for guiding therapy and preventing toxicity, especially in patients with renal impairment or receiving prolonged infusions. Target levels vary by indication.
* **Respiratory Rate:** Monitor for signs of respiratory depression (normal adult rate: 12-20 breaths/min).
* **Deep Tendon Reflexes:** Loss of reflexes is an early sign of hypermagnesemia.
* **Blood Pressure:** Monitor for hypotension, particularly with rapid IV administration.
* **Urine Output:** Adequate renal function is crucial for magnesium excretion.
* **Cardiac Rhythm:** Especially in patients with cardiac disease or receiving high doses.
## Clinical Pearls
* Magnesium sulfate should be administered slowly and cautiously, especially intravenously, to avoid hypotension and respiratory depression.
* In patients receiving magnesium for pre-eclampsia/eclampsia, monitor for signs of magnesium toxicity. Calcium gluconate is the antidote for magnesium toxicity.
* IM injections are painful; consider co-administration with a local anesthetic like procaine or lidocaine.
* The magnesium content of various magnesium sulfate formulations can differ. Always verify the mEq or gram content for accurate dosing.
---
*Please verify this information with the most current prescribing information and relevant institutional protocols before use.*
